The global recombinant proteins market is experiencing steady growth as pharmaceutical companies, biotechnology firms, and research institutions increasingly rely on engineered proteins for therapeutic development, drug discovery, and life sciences research. Recombinant proteins offer advantages such as high purity, consistent quality, controlled production, and reduced risk of animal-derived...